Tag: thrombosis

21-HVI-2500366 CQD 650×450

Platelet Olfactory Receptor Identified as Possible AAA Biomarker and Treatment Target

Investigations on platelet/aneurysm interactions lead to $2.6 million NIH grant

Depiction of a blood clot forming inside a blood vessel. 3D illustration

Immune Checkpoint Inhibitors May Enhance Cancer-Associated Thrombosis

Common cancer therapy increases serious risks in murine models

20-HVI-1979453_thrombotic-events-covid-19_650x450
October 26, 2020/COVID-19

Thrombotic Events in Symptomatic COVID-19: New Data Suggest Potentially Attenuated Risk

Our early experience shows lower-than-reported incidence, hints at role for neutrophilia

blood-clot_650x450
August 15, 2018/Research

Researchers Receive $4.7M NIH Grant to Prevent Cancer-Associated Thrombosis

Consortium aims to reduce life-threatening side effect of therapy

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

18-HRT-4781-Gut microbes blue-650×450

Nonlethal Targeting of Gut Microbes Inhibits Thrombosis with Minimal Bleeding Risk

Mouse study shows most potent therapeutic ‘drugging’ of microbiome to date

ABSORB II: bioresorbable stent
March 23, 2016/Research

Will Bioresorbable Scaffolds for Coronary Disease Pay Off Over the Long Term?

A PI’s perspectives on ABSORB III interim results

Gut Microbe-Dependent TMAO Promotes Platelet Hyperreactivity, Raises Thrombosis Risk
March 14, 2016/Research

Gut Microbe-Dependent TMAO Promotes Platelet Hyperreactivity, Raises Thrombosis Risk

Study raises prospect of new mechanism for preventing thrombotic events

CTscanner_690x380
August 3, 2015/News & Insight

Doing More Is Not Always Better

An NEJM Editorial

#ASCO_690x380
May 30, 2015/Research

Study Finds New Predictors of Recurring Cancer-Specific Thrombosis

Researchers see patient subgroups with higher clot risk

Restinosis
March 19, 2015/Research

3 Takes on 3 Emerging Strategies for Preventing Restenosis After Percutaneous Vascular Intervention

Drug-coated balloons, vascular brachytherapy, refining duration of dual antiplatelet therapy

BackPage 1 of 2Next
Advertisement
Ad